16 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
determines that an event, incident or circumstance has occurred that may result in the need for a recall or market withdrawal in the Territory … similar action in connection with the Licensed Compound or Licensed Product or in the event Licensor determines that an event, incident
F-3
EX-1.2
CNTB
Connect Biopharma Holdings Ltd
15 Apr 22
Shelf registration (foreign)
5:27pm
with the provisions of Section 11 hereunder, will pay all expenses incident to the performance of its obligations hereunder, including expenses
20-F
2021 FY
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
revenues, and other obligations incident to doing business in another country;
foreign reimbursement, pricing and insurance regimes;
difficulty … of potential loss, if any, that could result therefrom. If we cannot successfully resolve a security incident or contain any potential loss, it could
6-K
EX-99.1
1zhml
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.2
5gb2tib2njxx
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
424B4
6sk3va7sdex 1x2zigex
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
qg5vvy5fkbhfkqqweg
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
EX-1.1
0oe64yb
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
xhyvj4308d
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
b8gzk
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.1
81s5oqj
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
u2zo7bex63usom
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
b4i3wnyup2
17 Dec 20
Draft registration statement
12:00am
DRS
EX-10.1
z0asjpsx 0k9ozik5
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next